tricalcium phosphate has been researched along with clindamycin phosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, TA; Uskoković, V | 2 |
| Batarni, SS; Desai, TA; King, A; Schweicher, J; Uskoković, V | 1 |
3 other study(ies) available for tricalcium phosphate and clindamycin phosphate
| Article | Year |
|---|---|
Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Calcium Phosphates; Clindamycin; Delayed-Action Preparations; Humans; Mice; Nanoparticles; Osteoblasts; Osteomyelitis; Solubility; Staphylococcal Infections; Staphylococcus aureus | 2013 |
Effect of calcium phosphate particle shape and size on their antibacterial and osteogenic activity in the delivery of antibiotics in vitro.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Survival; Clindamycin; Core Binding Factor Alpha 1 Subunit; Cytoskeleton; Delayed-Action Preparations; Durapatite; Mice; Microbial Sensitivity Tests; Osteoblasts; Osteocalcin; Osteogenesis; Osteopontin; Particle Size; Staphylococcus aureus | 2013 |
Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Line; Cell Survival; Clindamycin; Cytoskeleton; Drug Carriers; Mice; Nanoparticles; Osteoblasts; Staphylococcus aureus | 2014 |